Tdap Vaccination for Infant Caregivers

Tdap Vaccination for Infant Caregivers in the Pediatric Office

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01233401

Enrollment

102

Registered

2010-11-03

Start date

2010-06-30

Completion date

2011-06-30

Last updated

2011-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pertussis, Vaccination

Keywords

Pertussis, Vaccination, Adult

Brief summary

This study evaluates whether offering Tetanus, diphteria and acellular pertussis (Tdap) vaccine to caregivers of newborn infants during pediatric well child visits increase the caregivers' vaccination rates.

Interventions

OTHERSurvey

Mothers and Other infant caregivers are surveyed at the end of the 2 week newborn well child visit about whether they chose to receive the Tdap vaccine at the pediatrician's office.

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to 64 Years

Healthy volunteers

Yes

Inclusion criteria

* 18-64 years old * English or Spanish speaking

Exclusion criteria

* Do not speak English or Spanish

Design outcomes

Primary

Measure	Time frame
Maternal Tdap Vaccination Rate	At 2 week well child visit

Secondary

Measure	Time frame
Other Infant Caregiver Tdap Vaccination Rate	At 2 week well child visit

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026